Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Treatment crawled time : 22:01 save search
UMH PROPERTIES, INC. ANNOUNCES TAX TREATMENT FOR 2020 DISTRIBUTIONS
Published: 2021-01-28 (Crawled : 22:01) - globenewswire.com
UMH 4 | $15.69 0.64% 0.0% 200K
|
Finance
|
| O: -0.53%
H: 1.0%
C: -1.93%
treatment distribution
MONMOUTH REAL ESTATE ANNOUNCES TAX TREATMENT FOR 2020 DISTRIBUTIONS
Published: 2021-01-26 (Crawled : 22:01) - globenewswire.com
MNR | $20.09 -0.94% 0.0% 72K
|
Finance
|
| O: -1.14%
H: 1.15%
C: -0.4%
treatment distribution
MeiraGTx To Present Clinical Program Update for AAV-hAQP1 Treatment of Radiation-Induced Xerostomia
Published: 2020-12-16 (Crawled : 22:01) - globenewswire.com
MGTX | $4.87 -1.22% -1.23% 110K
|
Health Technology
|
| O: 2.75%
H: 20.44%
C: 18.96%
treatment aav9 program
Cabaletta Bio Announces First Patient Dosed in Landmark DesCAARTes™ Trial of DSG3-CAART for Treatment of Mucosal-Dominant Pemphigus Vulgaris
Published: 2020-12-08 (Crawled : 22:01) - globenewswire.com
CABA | $12.94 -2.85% -2.94% 930K
|
Health Technology
|
| O: 1.98%
H: 0.0%
C: -3.19%
trial treatment
CEL-SCI’s LEAPS Peptides Demonstrate Clear Survival Benefit as a Treatment for COVID-19 in Preclinical Studies
Published: 2020-12-01 (Crawled : 22:01) - biospace.com/
CVM | $1.46 -0.68% 0.0% 76K
|
Health Technology
|
| O: 1.44%
H: 2.05%
C: -3.15%
covid treatment preclinical cel pre-clinical
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.